V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10444569 | 10033755 | 1.65 | 50 | Palliative (P) | 2019-10-06 | 2019-10-27 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101054314 |
| 10444575 | 10033756 | 1.52 | 85.5 | Neo-adjuvant (N) | 2021-02-18 | 2021-02-18 | IBRUTINIB | 02 | null | IBRUTINIB | 100314066 |
| 10444585 | 10033757 | null | 69.7 | Disease modification (D) | 2016-05-12 | 2016-05-12 | IBRUTINIB | 02 | N | IBRUTINIB | 100348045 |
| 10444586 | 10033758 | 1.69 | 72 | 03 | 2019-02-17 | 2019-02-17 | IBRUTINIB | 02 | N | IBRUTINIB | 100042011 |
| 10444592 | 10033759 | 1.65 | 89 | null | 2021-09-25 | 2021-10-17 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100944776 |
| 10444610 | 10033760 | 1.63 | 70.9 | Adjuvant (A) | 2021-12-30 | 2022-01-06 | PEMBROLIZUMAB | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101690911 |
| 10444626 | 10033761 | 1.66 | 42 | Palliative (P) | 2021-01-30 | 2021-02-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100630935 |
| 10444659 | 10033762 | 1.75 | 71.7 | Adjuvant (A) | 2014-08-25 | 2014-09-08 | Rituximab | 02 | N | RITUXIMAB | 100918884 |
| 10444662 | 10033763 | 1.85 | 74.2 | 03 | 2018-06-22 | 2018-06-24 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101058670 |
| 10444682 | 10033764 | 1.63 | 94 | Curative (C) | 2017-01-16 | 2017-01-18 | Rituximab | 02 | N | RITUXIMAB | 101700704 |
| 10444695 | 10033765 | 1.77 | 70.65 | null | 2021-06-15 | 2021-06-15 | IBRUTINIB | 02 | null | IBRUTINIB | 100301357 |
| 10444698 | 10033766 | 1.65 | 79.75 | 03 | 2017-09-12 | 2017-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101727393 |
| 10444704 | 10033767 | 1.72 | 61.8 | Neo-adjuvant (N) | 2017-11-25 | 2017-12-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101821027 |
| 10444717 | 10033768 | 1.65 | 68 | 03 | 2017-08-01 | 2017-08-18 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101659223 |
| 10444725 | 10033769 | 1.75 | 111 | null | 2016-09-06 | 2016-10-08 | CAPECITABINE + OXALIPLATIN | 99 | null | IBRUTINIB | 101524206 |
| 10444745 | 10033770 | 1.81 | 70.7 | Curative (C) | 2018-05-13 | 2018-05-26 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100255355 |
| 10444749 | 10033771 | 1.67 | 79.2 | 03 | 2018-11-18 | 2018-11-22 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100703349 |
| 10444808 | 10033772 | 1.72 | 80 | Palliative (P) | 2016-04-11 | 2016-04-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100531500 |
| 10444811 | 10033773 | 1.83 | 85.5 | null | 2018-07-23 | 2018-08-11 | IBRUTINIB | 02 | null | IBRUTINIB | 100523716 |
| 10444831 | 10033774 | 1.7 | 66 | Curative (C) | null | 2017-11-18 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101698298 |
| 10444859 | 10033775 | 1.73 | 101.2 | null | 2019-12-04 | 2019-12-04 | IBRUTINIB | 02 | null | IBRUTINIB | 100864514 |
| 10444866 | 10033776 | 1.6 | 80.3 | Palliative (P) | 2019-09-04 | 2019-09-16 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100097660 |
| 10444871 | 10033777 | 1.77 | 46.2 | Palliative (P) | 2016-01-25 | 2016-03-06 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101153859 |
| 10444872 | 10033778 | 1.57 | 52.15 | Adjuvant (A) | 2018-04-21 | 2018-05-05 | Capecitabine | N | N | CAPECITABINE | 101678871 |
| 10444887 | 10033779 | 1.72 | null | Adjuvant (A) | 2020-10-09 | 2020-10-09 | IBRUTINIB | 02 | N | IBRUTINIB | 100389961 |
| 10444888 | 10033780 | 1.73 | 94.05 | Curative (C) | 2021-11-26 | 2021-12-10 | CAPECITABINE + RT | 02 | null | CAPECITABINE | 101481964 |
| 10444890 | 10033781 | 1.64 | 101 | Curative (C) | 2017-09-20 | 2019-06-18 | IBRUTINIB | 02 | N | IBRUTINIB | 101786244 |
| 10444899 | 10033782 | 1.52 | null | Adjuvant (A) | 2018-04-10 | 2018-05-07 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE | 101626646 |
| 10444917 | 10033783 | 1.68 | 84.8 | Curative (C) | 2018-09-30 | 2018-10-06 | Capecitabine + Oxaliplatin 14day | 02 | N | PEMBROLIZUMAB | 100288958 |
| 10444918 | 10033784 | 1.75 | 118 | null | 2021-11-11 | 2021-11-14 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100788534 |
| 10444924 | 10033785 | 1.75 | 101.3 | Curative (C) | 2019-04-14 | 2019-05-09 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101368204 |
| 10444926 | 10033786 | 1.69 | 85.1 | Adjuvant (A) | 2019-05-19 | 2019-05-25 | Capecitabine | 02 | N | CAPECITABINE | 101559128 |
| 10444931 | 10033787 | 1.72 | 69.9 | null | 2019-09-20 | 2019-09-25 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100864330 |
| 10444978 | 10033788 | 1.71 | 76.8 | Palliative (P) | 2016-10-16 | 2016-10-16 | IBRUTINIB | 02 | N | IBRUTINIB | 101336019 |
| 10444994 | 10033789 | 1.9 | 73.8 | Palliative (P) | 2018-01-18 | 2018-01-22 | IBRUTINIB | 02 | N | IBRUTINIB | 101326828 |
| 10445066 | 10033790 | 1.68 | 58 | 03 | 2019-08-16 | 2019-10-05 | IBRUTINIB | 02 | null | PEMBROLIZUMAB | 101484345 |
| 10445088 | 10033791 | 1.63 | 75.8 | Palliative (P) | 2018-02-06 | 2018-02-10 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101777858 |
| 10445100 | 10033792 | 1.88 | 70.4 | 03 | 2017-05-12 | 2017-05-12 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100623163 |
| 10445101 | 10033793 | 1.62 | 82 | Palliative (P) | 2016-03-12 | 2016-03-22 | CAPECITABINE + RT | 02 | Y | CAPECITABINE | 100687824 |
| 10445110 | 10033794 | 1.86 | 71 | Palliative (P) | 2017-07-13 | 2017-07-31 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101126569 |
| 10445116 | 10033795 | 1.7 | 68.5 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-23 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100302787 |
| 10445127 | 10033796 | 1.71 | 80 | Adjuvant (A) | 2015-10-30 | 2015-10-30 | Capecitabine | 02 | N | CAPECITABINE | 100401796 |
| 10445133 | 10033797 | 1.74 | 67.8 | Curative (C) | 2016-09-30 | 2019-05-03 | IBRUTINIB | N | N | IBRUTINIB | 100056502 |
| 10445135 | 10033798 | 1.75 | 64.8 | Adjuvant (A) | 2019-08-01 | 2019-08-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100917525 |
| 10445156 | 10033799 | 1.67 | 63.3 | Palliative (P) | 2018-04-27 | 2018-05-03 | Docetaxel | 02 | N | DOCETAXEL | 101615253 |
| 10445166 | 10033800 | 1.6 | 101 | null | 2021-11-22 | 2021-11-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101418836 |
| 10445168 | 10033801 | 1.65 | 87.2 | Palliative (P) | 2019-06-06 | 2019-07-01 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100049066 |
| 10445171 | 10033802 | 1.57 | null | 03 | 2019-08-18 | 2019-08-30 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100375779 |
| 10445183 | 10033803 | 1.6 | 83.5 | Curative (C) | 2020-02-02 | 2020-02-07 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101721501 |
| 10445191 | 10033804 | 1.72 | 76.3 | null | 2021-09-24 | 2021-10-02 | Rituximab | 02 | null | RITUXIMAB | 101506741 |